Unconfigured Ad
Collapse
Techniques and protocol discussions on sample preparation, library generation, methods and ideas
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by lapensee, 11-29-2018, 05:27 AM
|
23 responses
16,662 views
0 reactions
|
Last Post
by Rosmano
10-23-2023, 03:32 AM
|
||
|
Started by tamas.malkocs, 09-28-2023, 05:04 AM
|
0 responses
149 views
0 reactions
|
Last Post
|
||
|
Started by zhaolin, 11-13-2014, 12:52 PM
|
11 responses
8,940 views
0 reactions
|
Last Post
by Rosmano
09-11-2023, 01:07 AM
|
||
|
Started by Leeenaaa, 02-21-2011, 01:43 AM
|
74 responses
53,223 views
0 reactions
|
Last Post
|
||
|
Started by ljmullen2, 06-24-2021, 11:39 AM
|
3 responses
3,863 views
0 reactions
|
Last Post
|
||
|
Started by aamur, 06-02-2023, 04:07 AM
|
1 response
381 views
0 reactions
|
Last Post
by deconti
06-05-2023, 12:43 AM
|
||
|
Started by yizhe2011, 08-23-2022, 04:39 AM
|
1 response
1,163 views
0 reactions
|
Last Post
by mama
05-31-2023, 09:41 AM
|
||
|
Started by Tarie, 05-16-2023, 08:47 AM
|
4 responses
339 views
0 reactions
|
Last Post
by Tarie
05-25-2023, 09:57 AM
|
||
|
Started by Amygdala, 10-15-2020, 08:41 AM
|
2 responses
3,008 views
0 reactions
|
Last Post
by aurman
05-15-2023, 08:47 AM
|
||
|
Started by samd199, 05-05-2023, 03:45 PM
|
0 responses
137 views
0 reactions
|
Last Post
by samd199
05-05-2023, 03:45 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is changing how clinical and public health laboratories detect pathogens, track antimicrobial resistance,...-
Channel: Webinar Series
Yesterday, 05:37 AM -
-
by SEQadmin2
Much of the genetic basis of Alzheimer's disease and related dementias (AD/ADRD) is still unexplained, and some of the answers may sit...-
Channel: Webinar Series
Yesterday, 05:06 AM -
Recent Articles
Collapse
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 09-29-2026, 09:51 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
09-29-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 09-25-2026, 09:06 AM
|
0 responses
40 views
0 reactions
|
Last Post
by SEQadmin2
09-25-2026, 09:06 AM
|
||
|
Started by SEQadmin2, 09-23-2026, 11:05 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
09-23-2026, 11:05 AM
|